Non-prescription pills draws controversy

Feb 05, 2007

A new plan in Britain that would allow birth control pills to be available for sale without prescription has some area doctors concerned, a report said.

Several British doctors have asked the Medicines and Healthcare Regulatory Authority to consider the new plan carefully because such medication sometimes can have major side effects, the Daily Mail reported.

While the proposal does call for any pharmacist offering birth control pills over the counter to check out a customer's medical history, the doctors remain concerned about the legislation.

They said the medication can especially prove dangerous to women who are already vulnerable to blood clots.

Those doctors will be given a chance to voice their opposition to the proposal at a meeting on Tuesday with drug industry representatives, along with National Health Service and other government officials.

The Daily Mail said similar legislation was previously passed for a migraine medication and cholesterol-lowering statins.

Copyright 2007 by United Press International

Explore further: New treatment approved for rare form of hemophilia

add to favorites email to friend print save as pdf

Related Stories

Video games target Japan's silver generation

Mar 06, 2014

At a nursing home in suburban Tokyo, 88-year-old Saburo Sakamoto darts his fingers energetically to catch characters that appear on a touch screen in front of him.

Emerging ethical dilemmas in science and technology

Dec 10, 2013

As a new year approaches, the University of Notre Dame's John J. Reilly Center for Science, Technology and Values has released its annual list of emerging ethical dilemmas and policy issues in science and ...

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

12 hours ago

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments : 0